Peri-implant disease (Mucositis and peri-implantitis) is a major and growing clinical problem in odontology, affecting 20-40 mill. patients in Europe, and the double worldwide. Labrida has developed, clinically documented and CE marked a novel, patented (pending) maintenance device for non-surgical management of peri-implant disease. It is a revision brush (“BioClean”), with bioresorbable bristles ...